Skip to main content
JAGX
NASDAQ Life Sciences

Jaguar Health Declares Special Convertible Preferred Stock Dividend, Signaling Significant Future Dilution

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$0.663
Mkt Cap
$2.304M
52W Low
$0.56
52W High
$25.75
Market data snapshot near publication time

Summary

Jaguar Health announced a special one-time dividend of Series O Convertible Preferred Stock, intended to protect existing shareholders from future dilution but carrying substantial risk of significant dilution upon conversion.


Key Events

  • Special Stock Dividend Declared

    The Board declared a one-time dividend of Series O Convertible Preferred Stock for each share of common stock and certain eligible warrants outstanding as of March 2, 2026.

  • Variable Conversion Terms

    The Series O Preferred Stock is convertible into common stock at the company's discretion or automatically by December 31, 2026, with a variable conversion ratio based on the common stock's market price at conversion.

  • Significant Dilution Risk Highlighted

    The filing explicitly warns that conversion could result in the issuance of a substantial number of common shares, potentially causing significant dilution for stockholders, especially those who do not receive the dividend.

  • Non-Transferable and Unlisted

    The Series O Preferred Stock is not transferable and will not be listed on any exchange, limiting liquidity and market value for recipients.


Analysis

Jaguar Health's declaration of a special one-time dividend of Series O Convertible Preferred Stock, while framed as a measure to protect existing shareholders from dilution, introduces a new and potentially severe dilutive mechanism. The Series O Preferred Stock is designed to convert into common stock at a variable ratio tied to the market price, with the company's own risk factors illustrating scenarios where this could lead to over 80% dilution of outstanding common stock. This move signals the company's ongoing financial distress and its need to manage substantial debt, as also evidenced by recent financing activities. The non-transferable and unlisted nature of the preferred stock further complicates its value for recipients. Investors should be aware of the significant overhang this convertible preferred stock creates, as its future conversion could substantially increase the number of common shares outstanding, negatively impacting the stock price and existing shareholder value. This action is part of a pattern of financing and debt management for a company facing recurring losses and Nasdaq listing challenges.

At the time of this filing, JAGX was trading at $0.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3M. The 52-week trading range was $0.56 to $25.75. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

JAGX - Latest Insights

JAGX
Jun 11, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.69
Real-time Price: $2.90 info
Change: +$0.210 (+8%) info
Market Cap: $1.698M info
JAGX
Jun 08, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.68
Real-time Price: $2.90 info
Change: +$0.220 (+8%) info
Market Cap: $1.698M info
JAGX
Jun 02, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.22
Real-time Price: $2.90 info
Change: -$0.320 (-10%) info
Market Cap: $1.698M info
JAGX
May 29, 2026, 5:23 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $3.46
Real-time Price: $2.90 info
Change: -$0.560 (-16%) info
Market Cap: $1.698M info
JAGX
May 27, 2026, 9:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.95
Real-time Price: $2.90 info
Change: -$0.050 (-2%) info
Market Cap: $1.698M info
JAGX
May 27, 2026, 9:10 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.95
Real-time Price: $2.90 info
Change: -$0.050 (-2%) info
Market Cap: $1.698M info
JAGX
May 22, 2026, 5:22 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.90
Real-time Price: $2.90 info
Change: $0 (0%) info
Market Cap: $1.698M info
JAGX
May 20, 2026, 4:36 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $3.67
Real-time Price: $2.90 info
Change: -$0.770 (-21%) info
Market Cap: $1.698M info
JAGX
May 20, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.67
Real-time Price: $2.90 info
Change: -$0.770 (-21%) info
Market Cap: $1.698M info
JAGX
May 20, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $3.36
Real-time Price: $2.90 info
Change: -$0.4599 (-14%) info
Market Cap: $1.698M info